Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1983 Dec;16(6):591–598. doi: 10.1111/j.1365-2125.1983.tb02227.x

Pulmonary effects in man of oral prizidilol hydrochloride (SK&F 92657), a new antihypertensive agent.

W M Edmondstone, J F Waller, K K Manghani, P L Hill, A J Bell, D M Denison
PMCID: PMC1428340  PMID: 6140939

Abstract

The effects on heart rate, blood pressure and pulmonary function of single oral doses of prizidilol hydrochloride (400 mg SK&F 92657) and propranolol (40 mg) were compared with placebo in nine healthy volunteers, in a double blind crossover study. Prizidilol had no effect on heart rate while propranolol caused a significant reduction compared with placebo. Diastolic blood pressure was lowered to the same extent by both prizidilol and propranolol. Propranolol significantly reduced the forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC) and the maximal expiratory flow at 50% vital capacity (MEF 50). Prizidilol had no effect on flow-volume loop parameters. Effective pulmonary blood flow was not altered by propranolol, but it was significantly increased by prizidilol. Oral prizidilol exerts its hypotensive effect by vasodilatation without reflex tachycardia. It does not cause airways obstruction in healthy subjects.

Full text

PDF
591

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Collier J. G., Pitcher D. W. Investigation of a combined arteriolar dilator and beta-adrenoceptor antagonist (SK & F 92657) in the peripheral vessels of man. Br J Clin Pharmacol. 1980 Dec;10(6):567–571. doi: 10.1111/j.1365-2125.1980.tb00512.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Denison D. M., Waller J. F. Interpreting the results of regional single-breath studies from the patient's point of view. Bull Eur Physiopathol Respir. 1982 Mar-Apr;18(2):339–351. [PubMed] [Google Scholar]
  3. Grieco M. H., Pierson R. N., Jr Mechanism of bronchoconstriction due to beta adrenergic blockade. Studies with practolol, propranolol, and atropine. J Allergy Clin Immunol. 1971 Sep;48(3):143–152. doi: 10.1016/0091-6749(71)90009-1. [DOI] [PubMed] [Google Scholar]
  4. Johnsson G., Svedmyr N., Thiringer G. Effects of intravenous propranolol and metoprolol and their interaction with isoprenaline on pulmonary function, heart rate and blood pressure in asthmatics. Eur J Clin Pharmacol. 1975 Apr 4;8(3-4):175–180. doi: 10.1007/BF00567111. [DOI] [PubMed] [Google Scholar]
  5. Kumana C. R., Kaye C. M., Leighton M., Turner P., Hamer J. Cardiac and pulmonary effects of acebutolol. Lancet. 1975 Jul 19;2(7925):89–93. doi: 10.1016/s0140-6736(75)90001-x. [DOI] [PubMed] [Google Scholar]
  6. Kumana C. R., Marlin G. E., Kaye C. M., Smith D. M. New approach to assessment of cardioselectivity of beta-blocking drugs. Br Med J. 1974 Nov 23;4(5942):444–447. doi: 10.1136/bmj.4.5942.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. MacLagan J., Ney U. M. A comparison of the bronchoconstrictor and beta-adrenoceptor blocking activity of propranolol and acebutolol. Br J Pharmacol. 1980 Feb;68(2):196–198. doi: 10.1111/j.1476-5381.1980.tb10407.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. McNeill R. S., Ingram C. G. Effect of propranolol on ventilatory function. Am J Cardiol. 1966 Sep;18(3):473–475. doi: 10.1016/0002-9149(66)90072-5. [DOI] [PubMed] [Google Scholar]
  9. Oh V. M., Kaye C. M., Warrington S. J., Taylor E. A., Wadsworth J. Studies of cardioselectivity and partial agonist activity in beta-adrenoceptor blockade comparing effects on heart rate and peak expiratory flow rate during exercise. Br J Clin Pharmacol. 1978 Feb;5(2):107–120. doi: 10.1111/j.1365-2125.1978.tb01609.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pierce R. J., Payne C. R., Williams S. J., Denison D. M., Clark T. J. Comparison of intravenous and inhaled terbutaline in the treatment of asthma. Chest. 1981 May;79(5):506–511. doi: 10.1378/chest.79.5.506. [DOI] [PubMed] [Google Scholar]
  12. Pitcher D. W., Curry P. V., Trounce J. R. An assessment of beta-adrenoceptor blockade in man by prizidilol hydrochloride. Br J Clin Pharmacol. 1982 May;13(5):711–716. doi: 10.1111/j.1365-2125.1982.tb01441.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Shaw R. J., Waller J. F., Hetzel M. R., Clark T. J. Do oral and inhaled terbutaline have different effects on the lung? Br J Dis Chest. 1982 Apr;76(2):171–176. [PubMed] [Google Scholar]
  14. Singh B. N., Whitlock R. M., Comber R. H., Williams F. H., Harris E. A. Effects of cardioselective beta adrenoceptor blockade on specific airways resistance in normal subjects and in patients with bronchial asthma. Clin Pharmacol Ther. 1976 May;19(5 Pt 1):493–501. doi: 10.1002/cpt1976195part1493. [DOI] [PubMed] [Google Scholar]
  15. Steiner J. A., Clancy A., Manghani K. K., James I. M. Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers. Br J Clin Pharmacol. 1981 Oct;12(4):573–578. doi: 10.1111/j.1365-2125.1981.tb01267.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Stone D. J., Sarkar T. K., Keltz H. Effect of adrenergic stimulation and inhibition on human airways. J Appl Physiol. 1973 May;34(5):624–627. doi: 10.1152/jappl.1973.34.5.624. [DOI] [PubMed] [Google Scholar]
  17. Taylor E. M., Roe A. M., Slater R. A. SK&F 92657, a novel antihypertensive acting by precapillary vasodilatation and beta-adrenoreceptor blockade. Clin Sci (Lond) 1979 Dec;57 (Suppl 5):433s–436s. doi: 10.1042/cs057433s. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES